genOway Société anonyme (EPA:ALGEN)
France
· Delayed Price · Currency is EUR 3.030
-0.020 (-0.66%)
Apr 1, 2025, 2:24 PM CET
genOway Société anonyme Revenue
genOway Société anonyme had revenue of 13.24M EUR in the half year ending June 30, 2024, with 32.33% growth. This brings the company's revenue in the last twelve months to 28.08M, up 23.42% year-over-year. In the year 2023, genOway Société anonyme had annual revenue of 26.51M with 25.70% growth.
Revenue (ttm)
28.08M
Revenue Growth
+23.42%
P/S Ratio
n/a
Revenue / Employee
219.39K
Employees
133
Market Cap
27.94M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 26.51M | 5.42M | 25.70% |
| Dec 31, 2022 | 21.09M | 1.30M | 6.58% |
| Dec 31, 2021 | 19.79M | 3.47M | 21.30% |
| Dec 31, 2020 | 16.31M | 2.04M | 14.26% |
| Dec 31, 2019 | 14.28M | -674.67K | -4.51% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 44.29B |
| EssilorLuxottica Société anonyme | 26.51B |
| Sartorius Stedim Biotech | 2.78B |
| bioMérieux | 3.98B |
| Eurofins Scientific SE | 6.95B |
| Ipsen | 3.57B |
| Virbac | 1.40B |
| emeis Société anonyme | 5.43B |